On February 16, 2023 IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, reported its participation in Citi’s 2023 Virtual Oncology Leadership Summit.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 2023 Virtual Oncology Leadership Summit
Tuesday, February 21, 2023 at 9:00 AM ET (6:00 AM PT)
Fireside chat with Yujiro S. Hata, President and Chief Executive Officer, hosted by
Yigal D. Nochomovitz, Ph.D., Director, SMid Cap Biotech Analyst.

A live audio webcast of the event will be available, as permitted by conference host, at the "Investors/ Events" section of the IDEAYA website at View Source A replay of the webcast will be accessible for 30 days following the live event.